ID
30582
Description
Study part: Local Laboratory- Hematology (Lab H). A phase 1 single-masked, randomized (with respect to placebo), placebo-controlled, parallel-group, dose-rising study to evaluate the safety, tolerability and pharmacokinetics of repeat oral doses of GW786034 in elderly healthy volunteers. Trade Name: Votrient. Clinical Study ID: MD1103367.
Keywords
Versions (1)
- 6/16/18 6/16/18 -
Copyright Holder
GlaxoSmithKline
Uploaded on
June 16, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Local Laboratory- Hematology (Lab H) Pazopanib Macular Degeneration MD1103367
Local Laboratory- Hematology (Lab H)
- StudyEvent: ODM
Similar models
Local Laboratory- Hematology (Lab H)
- StudyEvent: ODM
C1442065 (UMLS CUI [1,2])
C1442065 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
C0200345 (UMLS CUI [1,3])
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)